InflaRx Provides Update on Vilobelimab (IFX-1) Development

NEXT STORY
Turning Point Therapeutics Announces 2021 Milestone Targets
PREV STORY
Travere Therapeutics Provides Corporate Update and 2021 Outlook
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Inventiva to participate at the Stifel Virtual Healthcare Conference 2020 and the 11th Jefferies Virtual Healthcare Conference

author_avatar
NASDAQ Market News

Stemline Therapeutics Announces Three ELZONRIS Presentations, Including an Oral Presentation in Myelofibrosis, at Upcoming ASH Meeting

author_avatar
NASDAQ Market News

AEON Biopharma Appoints Dr. Chad K. Oh as Chief Medical Officer to Lead Clinical Development of ABP-450 Across Several Therapeutic Indications

author_avatar
NASDAQ Market News